15 Feb 2012
Scientists from the Tumour Angiogenesis Program at Peter Mac have made a biological breakthrough that explains how lymphatic vessels respond to cancer, shedding light on the anti-cancer effects of non-steroidal anti-inflammatory drugs (NSAIDs). This family of drugs can now be examined to see how we can best apply this knowledge to cancer therapies.
previous | next
OR